Xencor
XNCR • NASDAQ
Xencor is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bassil I. Dahiyat, with a market cap of $924.8M.
Market Cap$924.8M
Employees280.0
CEOBassil I. Dahiyat
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
XNC
Xencor FAQ
Common questions about Xencor
Xencor is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $27.9M.
Xencor has approximately 280 employees.